Search

everythinglearnresearchcommunity

for

Search:↓

Abolishing medical indication patents could hinder innovation in medicine.

Laser hair removal may cause skin changes that prevent hair regrowth.

EPC-K is stable except at very acidic pH or when exposed to sunlight, and it can decompose in low ethanol concentrations.

EPC-CM can reduce skin aging signs by boosting the skin's defense system.

miR-150 helps blood vessel cells develop and speeds up blood clot healing.

European patent law now allows patents for new uses and dosages of known drugs, but protection scope is unclear.

A new method efficiently creates cell spheres that help regenerate hair.

The revised European Patent Convention may limit generic drug use, affecting healthcare professionals' treatment choices.

UK courts and the European Patent Office are now more open to granting patents for new dosage regimes.

A new topical treatment using micelles shows promise for safer and more effective hair regrowth in androgenetic alopecia.

The UK Intellectual Property Office allows granting of supplementary protection certificates with negative terms.

Early onset baldness in men may indicate a condition similar to PCOS, linked to heart disease, diabetes, and prostate issues.

Human body's immune cells are more common in the layer of fat just beneath the skin than in deeper fat layers.

The document concludes that stem cells and their environments are crucial for skin and hair health and have potential for medical treatments.

Different cells affect hair follicle blood vessels, endothelial cells react differently to inflammation and oxidized fats, and prasugrel better protects heart vessels during a procedure than clopidogrel.

Prasugrel is better than clopidogrel at preventing heart damage and improving blood flow in small heart vessels during heart artery procedures.

The UK Court of Appeal ruled that new dosing regimens for drugs can be patented, aligning with the European Patent Office's approach.

Australian court ruled that Bickfords did not infringe on Monster Energy's trade mark because Monster was not sold or known in Australia at the time.

The document concludes that better targeted treatments are needed for wound healing, and single-cell technologies may improve cell-based therapies.

Fat tissue-derived cells show promise for repairing body tissues, but more research and regulation are needed for safe use.

Ets2 gene is crucial for placental development in mice.

Stem cell-derived conditioned medium shows promise for treating various medical conditions but requires standardized production and further validation.

Fat-derived stem cells show promise for skin repair and reducing aging signs but need more research for consistent results.

Microneedling is a safe and effective treatment for various skin conditions, often preferred for its fewer side effects and shorter recovery time.

Conditioned media from mesenchymal stem cell cultures could be a more effective alternative for regenerative therapies, but more research is needed.

Extracellular vesicles show promise for treating diseases but face challenges in development and regulation.

Engineered exosomes show promise for improving wound healing but face challenges in clinical use.

Electrospun nanofibers show promise for enhancing blood vessel growth in tissue engineering but need further research to improve their effectiveness.

Toll-like receptors are important for wound healing, but can slow it down in diabetic wounds.